Understand the WHO/ISUP classification system. Define Grade Group 2, how this intermediate-risk prostate cancer is determined, and the resulting management pathways.
Discover the critical difference between SubQ and IM injections, detailing the rapid pharmacokinetic shifts and localized consequences of misplacement.